oncotype dx login

oncotype dx login

Searching for oncotype dx login? Use official links below to sign-in to your account.

If there are any problems with oncotype dx login, check if password and username is written correctly. Also, you can contact with customer support and ask them for help. If you don't remember you personal data, use button "Forgot Password". If you don't have an account yet, please create a new one by clicking sign up button/link.

www.oncotypeiq.com › en-GB › breast-cancerOrdering the Test | Oncotype DX® Test | Oncotype IQ® United ...

    https://www.oncotypeiq.com/en-GB/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/how-to-order-a-test
    Contact Customer Support at [email protected] if you did not receive your activation email or would like to signup for an online ordering account. Go to online.genomichealth.co.uk and login with your new credentials to place order or read reports online. STEP 3 of 5 Prepare the specimen for submission.
    Status:Page Online
    https://www.oncotypeiq.com/en-GB/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/how-to-order-a-test

www.oncotypeiq.com › en-US › prostate-cancerGenomic Approach | Oncotype DX GPS(TM) | Oncotype IQ®

    https://www.oncotypeiq.com/en-US/prostate-cancer/healthcare-professionals/oncotype-dx-genomic-prostate-score/genomic-approach
    The Oncotype DX Genomic Prostate Score was developed in collaboration with the Cleveland Clinic and UCSF to specifically address the many challenges inherent to prostate cancer risk assessment. 3-4. The genes in the Oncotype DX GPS assay were chosen for their 3: Correlation with tumor aggressiveness regardless of multifocality or heterogeneity
    Status:Page Online
    https://www.oncotypeiq.com/en-US/prostate-cancer/healthcare-professionals/oncotype-dx-genomic-prostate-score/genomic-approach

Genomic Health Online

    https://oncotype.online.genomichealth.com/
    More than 900,000 patients tested worldwide LOG IN Username Enter your Portal username Password Enter your Portal password Need help signing in?
    Status:Page Online

Portal Signup - Oncotype IQ

    https://www.oncotypeiq.com/en-US/contact/portal-signup/role
    Signup for an Account Physician Login Oncotype DX Online Ordering Portal Signup By signing up, physicians and delegates can have access to the benefits of Exact Sciences' online ordering portal. Secure and HIPAA compliant portal Place orders online any time Assign delegates to place your orders ...
    Status:Page Online
    https://www.oncotypeiq.com/en-US/contact/portal-signup/role

www.medpagetoday.com › meetingcoverage › additionalIs Sentinel Node Biopsy Necessary for Older Breast Cancer ...

    https://www.medpagetoday.com/meetingcoverage/additionalmeetings/98107
    Apr 07, 2022 · Slightly more women 70 years or older with these early breast cancers had chemo-qualifying Oncotype DX 21-gene recurrence scores (>26) if node positive than if node negative (14.7% vs 13.1%).
    Status:Page Online
    https://www.medpagetoday.com/meetingcoverage/additionalmeetings/98107

Making cancer care smart with Oncotype DX tests | Oncotype IQ®

    https://www.oncotypeiq.com/en-US
    To make cancer care smart at every stage, our Oncotype IQ diagnostic tests and services portfolio delivers clinically relevant genomic intelligence that reveals the individual biology of a patient's tumor. EXPLORE THE PORTFOLIO The only genomic test proven to predict a patient's individual benefit from chemotherapy. About the Test NEW DATA
    Status:Page Online
    https://www.oncotypeiq.com/en-US

www.cancercenter.com › diagnosing-cancer › lab-testsLab & Blood Tests For Cancer Diagnosis and Treatment | CTCA

    https://www.cancercenter.com/diagnosing-cancer/lab-tests
    Mar 02, 2022 · The Oncotype DX test may be used if: You have stage 1, 2 or 3A hormone receptor-positive tumors that are also HER2-negative, and that have spread to fewer than three lymph nodes. Your breast cancer is stage 0 (ductal carcinoma in situ). The results of the Oncotype DX test may help determine whether you would benefit from chemotherapy.
    Status:Page Online
    https://www.cancercenter.com/diagnosing-cancer/lab-tests

Log in

    https://www.theoncotypedx.com/
    Licenses & Accreditations | Privacy Policy | Terms & Conditions © 2022 Genomic Health, All rights reserved.
    Status:Page Online
    https://www.theoncotypedx.com/

www.huskyhealthct.org › providers › formsHUSKY Health Program | HUSKY Health Providers | Provider Forms

    https://www.huskyhealthct.org/providers/forms.html
    For help locating a specialist, other provider, or community resources for your HUSKY Health patients. Please fax to 203.265.3197 or e-mail to [email protected].
    Status:Page Online
    https://www.huskyhealthct.org/providers/forms.html

Personalising Treatment Decisions | Oncotype DX® Tests ...

    https://www.oncotypeiq.com/en-GB
    The Oncotype DX test reveals the underlying tumour biology to help guide treatment decisions. The Oncotype DX ® test should be used when the benefit of chemotherapy for a patient is uncertain. The landmark TAILORx results provide definitive answers on which early stage ER+, HER2-, N0 breast cancer patients can benefit from chemotherapy.
    Status:Page Online
    https://www.oncotypeiq.com/en-GB

www.breastsurgeons.org › meeting › 2022Annual Meeting Agenda - 2022 Annual Meeting | ASBrS

    https://www.breastsurgeons.org/meeting/2022/agenda
    Oncotype Dx scores and Nodal Status in Patients over 70 years old – Continue to Choose Wisely Kyra Nicholson, MD Margin Management and Adjuvant Therapy for Phyllodes Tumors: Practice Patterns of the American Society of Breast Surgeons Members
    Status:Page Online
    https://www.breastsurgeons.org/meeting/2022/agenda

www.nature.com › articles › s41591/018/0136-1Signatures of T cell dysfunction and ... - Nature Medicine

    https://www.nature.com/articles/s41591-018-0136-1
    Aug 20, 2018 · Gene expression biomarkers, such as Oncotype DX 11, MammaPrint 12 and Prosigna 13, have demonstrated clinical utility in predicting treatment benefits in breast cancer. We hypothesize that ...
    Status:Page Online
    https://www.nature.com/articles/s41591-018-0136-1

Personalising Treatment Decisions| Oncotype DX® Tests ...

    https://stage.oncotypeiq.com/en
    The Oncotype DX ® test reveals the underlying tumour biology to help guide treatment decisions. Only a truly predictive test can identify the right treatment for the right patient. The landmark TAILORx results provide definitive answers on which early stage ER+, HER2-, N0 breast cancer patients can benefit from chemotherapy.
    Status:Page Online
    https://stage.oncotypeiq.com/en

How to Order the Oncotype DX Breast Recurrence Score ...

    https://www.oncotypeiq.com/en-US/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/how-to-order-a-test
    Ordering an Oncotype DX test and receiving the results is a straightforward process. Simply follow these 4 steps. STEP 1 - Obtain a specimen kit Exact Sciences provides a specimen transportation kit box for each patient's tissue sample. To request specimen transportation kit boxes contact the Customer Service team at 866-ONCOTYPE ( 866-662-6897)
    Status:Page Online
    https://www.oncotypeiq.com/en-US/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/how-to-order-a-test

About the Oncotype DX® Breast DCIS Score(TM) | Oncotype IQ®

    https://akamai.oncotypeiq.com/en-US/breast-cancer/healthcare-professionals/oncotype-dx-breast-dcis-score/about-the-test
    The Oncotype DX Breast DCIS Score test is the first clinically-validated, commercially available genomic test for patients with DCIS. It looks at the unique biology of a patient's tumor—so you can better personalize the treatment plan for each patient's unique situation.
    Status:Page Online
    https://akamai.oncotypeiq.com/en-US/breast-cancer/healthcare-professionals/oncotype-dx-breast-dcis-score/about-the-test

Comparing Other Tests | Oncotype DX Breast Recurrence ...

    https://stage.oncotypeiq.com/en-US/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/how-does-it-compare-to-other-tests
    The Oncotype DX portfolio includes tests for breast, colon, and prostate cancer and have helped more than 1 million patients make more informed treatment choices. 1 The flagship product in the portfolio is the Oncotype DX Breast Recurrence Score test for early-stage, ER+, HER2- invasive breast cancer. The test delivers critical genomic information to guide treatment decisions that no other ...
    Status:Page Online
    https://stage.oncotypeiq.com/en-US/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/how-does-it-compare-to-other-tests

Insurance & Financial Assistance | Oncotype DX Breast ...

    https://stage.oncotypeiq.com/en-US/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/insurance-coverage-and-financial-assistance
    Exact Sciences is committed to supporting patient access to the Oncotype DX Breast Recurrence Score test to help your patients make informed decisions about their treatment.. Financial Responsibility Information. Out-of-pocket costs for the Oncotype DX Breast Recurrence Score test, if any, are determined by the insurance company.
    Status:Page Online
    https://stage.oncotypeiq.com/en-US/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/insurance-coverage-and-financial-assistance

Oncotype DX - Susan G. Komen®

    https://www.komen.org/breast-cancer/diagnosis/factors-that-affect-prognosis/oncotype-dx/
    Oncotype DX is the most common tumor profiling test used in the U.S. Other tumor profiling tests, such as MammaPrint ® and PAM50 (also called Prosigna ®), are available. Oncotype DX is the only one used in breast cancer staging. Oncotype DX testing. Oncotype DX tests a sample of the tumor (removed during a biopsy or surgery) for a group of 21 ...
    Status:Page Online
    https://www.komen.org/breast-cancer/diagnosis/factors-that-affect-prognosis/oncotype-dx/

How to Order | Oncotype DX Colon Recurrence Score ...

    https://akamai.oncotypeiq.com/en-US/colon-cancer/healthcare-professionals/oncotype-dx-colon-recurrence-score/how-to-order-a-test
    STEP 1 - Get specimen kits. Exact Sciences provides a specimen transportation kit box for each patient's tissue sample. Request specimen transportation kit boxes by contacting Customer Service at 866-ONCOTYPE ( 866-662-6897) or email us with your information. Kit orders usually arrive to you within 48 hours.
    Status:Page Online
    https://akamai.oncotypeiq.com/en-US/colon-cancer/healthcare-professionals/oncotype-dx-colon-recurrence-score/how-to-order-a-test

Genomic Health Online

    https://online.genomichealth.co.uk/
    Physician Portal. More than one million patients tested worldwide. Authentication . Login
    Status:Page Online

Oncotype DX test | CTCA

    https://www.cancercenter.com/cancer-types/breast-cancer/diagnosis-and-detection/oncotype-dx-test
    The Oncotype DX ® test is a type of gene expression test used widely in the United States for breast cancer.It helps doctors learn more about the chances of cancer recurring and determine whether you'd get an added benefit from chemotherapy (and, in some cases, radiation therapy) as part of your treatment plan.. The Oncotype DX test uses genetic material from cancer cells to predict how ...
    Status:Page Online
    https://www.cancercenter.com/cancer-types/breast-cancer/diagnosis-and-detection/oncotype-dx-test

Report Your Problem